Demographic characteristics of participants in clinical trials to treat Alzheimer disease, 2008–2023

Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment

(2021) Timothy S. Anderson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial

(2021) Rema Raman et al.   JAMA Network Open

What the Aducanumab Approval Reveals About Alzheimer Disease Research

(2021) Jennifer J. Manly et al.   JAMA Neurology

Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials

(2020) Ayman Samman Tahhan et al.   JAMA Cardiology

Participation of Women and Older Participants in Randomized Clinical Trials of Lipid-Lowering Therapies

(2020) Safi U. Khan et al.   JAMA Network Open

Representativeness of Randomized Clinical Trial Cohorts in End-stage Kidney Disease

(2019) Brendan Smyth et al.   JAMA Internal Medicine

Strategies addressing barriers to clinical trial enrollment of underrepresented populations: A systematic review

(2014) Caren Heller et al.   Contemporary Clinical Trials

Participation of Women and Sex Analyses in Late-Phase Clinical Trials of New Molecular Entity Drugs and Biologics Approved by the FDA in 2007–2009

(2013) Rita Poon et al.   JOURNAL OF WOMENS HEALTH